Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us") announced today preliminary selected financial results for the year ended December 31, 2025. Based on preliminary data, the Company ...

National Vision Reaffirms Fiscal 2025 Outlook Ahead of Participation at the ICR ConferenceThe Associated PressDULUTH, Ga. DULUTH, Ga.–(BUSINESS WIRE)–Jan 13, 2026– National Vision Holdings, Inc.

A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and ...

CT is one of the most widely used diagnostic imaging tools, but accurately estimating patient radiation dose remains ...

Roche Holding shares rose 2.1% Wednesday after the Swiss drugmaker reported positive results from a new study of an experimental breast cancer drug. The pill, giredestrant, reduced the risk of death ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. If you're finding your grocery bills are higher than you'd like, you might want to consider having a ...

FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal date is July 29, 2026. NRx has applied to FDA for use of ...